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ABStrAct
This pilot study assessed the extent to which health care providers in HIV care and treatment, 
substance abuse intervention and employee assistance programmes (EAPs) consider and inform 
their clients about the role of alcohol use/abuse in HIV transmission, HIV disease progression and 
adherence to antiretroviral therapy (ART). A web- and telephone-based survey was conducted 
among 84 of the aforementioned programmes. Albeit not routinely, respondents from most 
organisations reported addressing the issues of alcohol in HIV transmission, disease progression 
and ART adherence among their clients. Contrary to expectations, many programmes do consider 
the links between alcohol and HIV and AIDS in their operations, but seem to lack adequate 
resources, information and skills to intervene in a comprehensive way.
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introDuction
South Africa has the greatest number of 
people living with HIV infection in the world 
(UNAIDS, 2007) and is among countries with 
the highest levels of hazardous alcohol use 
(Parry, 2005); that is,“a pattern of substance 
use that increases the risk of harmful conse-
quences for the user” (Babor et al., 1994, p. 
41). Within sub-Saharan Africa, the burden of 
the HIV epidemic is not evenly distributed, 
and Southern Africa is the sub-region which 
is most affected. It is estimated that in 2007 
Southern Africa accounted for 35% of all 
people living with HIV and 32% of all new 
infections and AIDS-related deaths globally 
(UNAIDS, 2007).
Alcohol use (including hazardous use, 
harmful use and alcohol dependence) is in-
creasingly known to impact on at least three 
main aspects of HIV disease, namely, HIV 
transmission, HIV disease progression and 
adherence to HIV medication. Harmful use 
refers to “a pattern of”(... alcohol use...) “that 
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is causing damage to health” (Babor et al., 
1994; p.41), and alcohol dependence refers 
to “a cluster of behavioural, cognitive, and 
physiological phenomena that may develop 
after repeated alcohol use”...inclusive of...“a 
strong desire to consume alcohol, impaired 
control over its use, persistent drinking de-
spite harmful consequences, a higher priority 
given to drinking than to other activities and 
obligations, increased alcohol tolerance, and 
a physical withdrawal reaction when alcohol 
use is discontinued (Babor et al., 2001, p. 5). 
Encouragingly, the South African Department 
of Health’s HIV and AIDS and STI Strategic 
Plan for South Africa, 2007-2011 (Department 
of Health, 2007) recognises the role played 
by alcohol and other substances of abuse (i.e. 
substances that can “change an individual’s 
consciousness, mood or thinking processes”; 
World Health Organization [WHO], 2004, pp. 
1-2) in the transmission of HIV, and highlights 
the need for programmes to address this chal-
lenge. However, it makes little mention of al-
cohol’s effects on antiretroviral (ART) medica-
tion adherence and HIV disease progression.
Much research that has been carried out in 
sub-Saharan Africa has highlighted alcohol’s 
role in HIV transmission. A recent systematic 
review of studies conducted in Southern Africa 
has shown that alcohol use is associated with in-
creased involvement in sexual risk behaviours 
which lead to infection with HIV (Kalichman, 
Simbayi, Kaufman, Cain & Jooste, 2007). Al-
cohol use also increases the likelihood of HIV 
infected individuals engaging in sexual risk be-
haviour, thereby re-infecting themselves and/
or infecting others. A number of studies have 
found a high prevalence of alcohol use in HIV 
positive individuals (e.g. Shaffer et al., 2004; 
Simbayi et al., 2007). Indeed, a systematic re-
view and meta-analysis of studies conducted in 
Africa (Fisher et al., 2007) has indicated that 
those who drink alcohol tend to be more likely 
than non-drinkers to be HIV-positive, with the 
association becoming even stronger for per-
sons who are problem drinkers (which, in the 
reviewed studies, was variously defined, based 
on scores on the AUDIT and CAGE; alcohol 
consumption patterns, including ≥ 3 drinks per 
occasions; frequency of alcohol consumption; 
and daily consumption).
There is also growing evidence that heavy 
alcohol use (i.e. the consumption of alcohol in 
levels that exceed “some standard of moderate 
drinking or – more equivocally – social drink-
ing”; WHO, 2004, p.26) is negatively associ-
ated with adherence to ART. The same holds 
true for the heavy use of other drugs. The asso-
ciation between the two behaviours is complex 
(Parsons, Rosof, Punzalan, & di Maria, 2005), 
and proposed to be mediated by a number of 
cognitive and behavioural factors. First, heavy 
substance use has been hypothesised to impact 
adherence negatively as it leads to impaired 
cognition, judgment and short-term memory 
(Murphy, Marelich, Hoffman & Steers, 2004; 
Parsons et al., 2005), all of which are cogni-
tive functions vital for navigating some of the 
complex antiretroviral regimens (Hinkin et 
al., 2002; Hinkin et al., 2004). Second, beliefs 
that substances of abuse interact negatively 
with ART drugs are purported to account for 
the relationship between substance use and 
ART non-adherence. For example, individuals 
may consciously decide to forgo taking their 
ART when drinking alcohol in order to avoid 
the negative alcohol-ART interactions that 
they believe result from the ingestion of both 
substances concurrently (Sankar et al., 2007). 
Third, since heavy alcohol or other drug use 
may hinder patients’ health-protective behav-
iours such as keeping a doctor’s appointment 
(Turner et al., 2001), it is proposed that sub-
stance use could lead to missed opportunities 
for receiving adherence counselling or other 
advice from health care providers regarding 
various aspects of their treatment regimen.
Alcohol use has also been shown to has-
ten HIV disease progression (Conigliaro et 
al., 2003; Fabris et al., 2000, Hao rah et al., 
2004; Samet, Horton, Traphagen, Lyon, & 
Freedberg, 2003; Miguez, Shor-Posner, Mo-
rales, Rodriguez & Burbano, 2003; Wang et 
al., 2002). With a few exceptions (e.g. Fab-
ris et al., 2000), the evidence for this effect is 
particularly compelling for patients on ART 
(Samet et al., 2003; Miguez, Shor-Posner, Mo-
rales, Rodriguez & Burbano, 2003). A number 
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of mechanisms have been proposed to explain 
this relationship. First, alcohol (ethanol) has 
an impact on proteasomes and immunopro-
teasomes; critical immune processes that are 
attenuated during progressive HIV-1 infection 
(Hao rah et al., 2004). Second, it is hypoth-
esized that alcohol-exacerbated hepatotoxicity 
may reduce the efficiency of the liver, hence 
leading to less bioavailable ART to curtail the 
replication of HIV. For example, in a prospec-
tive cohort study of 881 HIV-positive veterans 
in the USA, hazardous drinking/alcohol abuse 
was associated with HIV disease progres-
sion and/or hepatic comorbidity and anaemia 
(Conigliaro et al., 2003). Third, drug-drug in-
teractions between alcohol and ART are pos-
ited to accelerate the progression of the dis-
ease. Studies with human monocyte-derived 
macrophages support the notion that HIV-1 
infection and ethanol may act synergistically 
to affect immune function including antigen 
presentation, hence speeding up disease pro-
gression (Hao rah et al., 2004). Finally, the link 
between alcohol use and HIV disease progres-
sion is thought to be mediated by ART non-ad-
herence (Samet et al., 2003). In other words, as 
a result of their use of alcohol individuals may 
be less likely to take their antiretroviral (ARV) 
medications as regularly as prescribed.
Given the evidence from the above studies, 
interventions to address heavy alcohol con-
sumption may (a) reduce individuals’ chances 
of engaging in HIV-related sexual risk behav-
iours; (b) slow down the rate of HIV disease 
progression, particularly among those who are 
receiving ART; and (c) reduce levels of non-
adherence to ART. However, it is not clear 
whether health care and service providers in 
South Africa actually acknowledge and apply 
this information in their daily practice.
With some exceptions (e.g. Myers & Fak-
ier, 2007), very few studies have examined 
whether knowledge about the role of alcohol 
abuse in HIV disease is utilised by health care 
providers in South Africa. Myers and Fakier 
found that 52% and 49% of substance abuse 
services in the provinces of Gauteng and 
KwaZulu-Natal, respectively, provide HIV 
risk reduction interventions/HIV testing and 
counselling. However, few studies conducted 
in South Africa have assessed whether HIV 
prevention and treatment programmes or em-
ployee assistance programmes (EAPs) rec-
ognise and inform their clients about the role 
of heavy alcohol (and other drug) use in HIV 
transmission, disease progression and adher-
ence to HIV medication in their daily practice. 
Such knowledge can be useful for informing 
the implementation of many aspects of the Na-
tional HIV and AIDS and STI Strategic Plan 
(Department of Health, 2007) as well as other 
national planning tools such as the National 
Drug Master Plan which broadly highlights 
the need to address the links between sub-
stance use and sexually transmitted infections, 
such as HIV and AIDS (Department of Social 
Development, 2007). The primary aim of this 
pilot study was to assess the extent to which 
HIV care and treatment, substance abuse, and 
employee assistance programmes in South 
Africa consider and inform their clients about 
the role of alcohol use/abuse in HIV transmis-
sion, HIV disease progression and adherence 
to ART. The study considered other drugs as 
a secondary concern, hence information was 
also sought from the various programmes re-
garding the extent to which they consider and 
inform their clients about the role of other 
drugs in HIV transmission, HIV disease pro-
gression and adherence to ART.
MethoD
Design
The pilot study involved a cross-sectional 
survey that was carried out between Novem-
ber 2005 and May 2006.
Participants/organisations
Participants comprised service providers 
(and not clients/users) within three sectors: the 
HIV prevention, care and treatment sector, the 
substance abuse prevention and treatment sec-
tor, and the private industry sector. The first 
two sectors were selected in order to include 
programmes that provide services specifically 
for people who are risk of developing problems 
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related to HIV and/or substance use, and/or are 
already experiencing substance use or HIV-re-
lated problems. The private industry sector was 
selected in order to focus on Employee Assis-
tance Programmes (EAPs) dealing specifically 
with HIV and AIDS and/or alcohol and other 
drug use problems. For the sampling of organi-
sations, we sought to include all HIV care and 
treatment organisations that were listed in the 
Centre for HIV/AIDS Networking’s database 
of HIV-related organisations as having sub-
stance abusers among their clients. We also 
targeted all substance abuse programmes that 
were included in the substance abuse direc-
tory of services of the Central Drug Authority 
(Central Drug Authority, 2003), and excluded 
research and academic institutions, as the pi-
lot study was concerned with the practices of 
health care and health service providers. The 
EAPs were those that ran substance abuse and 
HIV programmes for their employees.
Questionnaire
The questionnaire consisted of ten sets of 
items: eight close-ended and two open-ended 
(please see the Appendix for a copy of the 
questionnaire). The questions asked about the 
following aspects of service delivery:
1.  The extent to which the programme consid-
ers the role of alcohol use in HIV transmis-
sion, disease progression, and adherence to 
HIV treatment.
2.  Whether the programme informs its cli-
ents about the role of alcohol use in HIV 
transmission, disease progression and ad-
herence to HIV treatment via written com-
munication and/or verbal communication 
and/or referral.
3.  Whether the programme considers the role 
of the use of substances other than alcohol 
in HIV transmission and/or disease pro-
gression and/or HIV treatment adherence.
4.  Whether the organisation has resources to 
address these issues.
On average the questionnaire would take 
about 5 minutes to complete.
Procedures
Web-based survey
The web-based survey was implemented by 
the webmaster of the Medical Research Coun-
cil (MRC) in Cape Town and hosted on the 
MRC’s website. Data collection was initiated 
by sending a brief introductory letter by email 
to all of the eligible service providers inviting 
them to participate in the audit. The introduc-
tory electronic mail was embedded with a hy-
perlink that directed prospective participants 
to a webpage displaying an information leaflet 
and informed consent form. Separate informa-
tion leaflets about the study were available 
for participants from each of the sectors, i.e. 
the HIV services sector, the substance abuse 
treatment and prevention programmes, and 
the EAP sector. Those prospective participants 
who were willing to complete the question-
naire indicated their willingness to do so by 
entering their name and electronic mail ad-
dress onto the consent form and then clicking 
on a box displaying the words “I agree”. Those 
who did not consent to participate in the study 
clicked a box displaying the words “I do not 
agree”. They were then directed to a webpage 
displaying the words “Thank you for taking 
the time to read the information”, and did not 
have access to the questionnaire. In those in-
stances where the electronic mails were un-
delivered, the organisations were contacted 
telephonically in order to verify their correct 
email address, and the introductory letter was 
then resent to the updated email address.
Telephone survey
Telephone interviews were conducted 
among service providers of those organisations 
that did not have access to e-mail and those 
that did not respond to the web-based survey. 
Data collection was initiated by introducing 
the study to the recipient of the telephone call 
who was then asked to direct the call to the ap-
propriate person/department. After introduc-
ing the study to the prospective participant, 
the consent form was read aloud and time was 
given to answer any possible questions the par-
ticipant might have had. Verbal consent was 
then provided and the interview commenced. 
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The entire procedure took about 20 minutes 
to complete.
Ethical approval for conducting the study 
was granted by the University of Pretoria’s 
Faculty of Health Sciences Research Ethics 
Committee.
reSultS
Table 1 shows the number of questionnaires 
that were completed, refusals received and or-
ganisations that were not contactable. Many 
organisations could not be contacted due to 
disconnected telephones and wrong numbers 
listed. In some instances service providers did 
not have time to complete the survey due to 
staff shortages. A total of 84 questionnaires 
were completed; a response rate of 43%. The 
refusal rate was just over 5% for organisations 
contacted telephonically.
The types of services that were provided by 
the HIV prevention, care and treatment and 
substance abuse programmes that participated 
in the study can be seen in Table 2. The major-
ity of HIV care and treatment programmes in-
cluded in the study were based in clinical set-
tings, whereas community-based settings and 
rehabilitation centres were predominant for 
substance abuse programmes. The substance 
abuse programmes were based mainly in Gau-
teng (30%), KwaZulu-Natal (25%) and the 
Western Cape (21%) provinces, while a few 
organisations were located in each of the other 
provinces barring the Northern Cape. The vast 
majority (80%) of the HIV programmes were 
based in Kwa-Zulu Natal, while there were 
two in the Eastern Cape, and one each in the 
Free State, Gauteng and Western Cape prov-
inces. The EAPs included in the study deliver 
services to employees within as many as a few 
hundred companies around South Africa. The 
types of companies to which they delivered 
their programmes were mainly within the in-
surance, telecommunications, hotel, banking 
and retail sectors.
Screening for Alcohol and other Drug 
Abuse/Dependence
Table 3 shows the frequency with which 
the organisations reportedly screened their 
clients for alcohol abuse/dependence and oth-
er drug abuse/dependence. As expected, the 
participants from the substance abuse pro-
grammes were significantly more likely than 
those from the HIV programmes to report 
screening their clients. Two of the three EAP 
participants reported that their organisations 
did sometimes screen their clients for alcohol 
abuse/dependence, but none of the EAPs re-
portedly screened their clients for other drug 
abuse/dependence.
Alcohol and hiV
Participants from all of the HIV preven-
tion, care and treatment programmes (100%) 
and most of the substance abuse programmes 
(96%) confirmed that they did spend at least 
some time informing their clients about the 
links between alcohol and HIV in general. 
Respondents from most of the HIV prevention 
table 1: Response Rate for HIV, Substance Abuse and Employee Assistance Programmes
responses










N (%) N (%) N (%) N (%)
Questionnaires completed 25 (28) 56 (53) 3 (100)  84 (43)
Telephonic refusals*  6 ( 7)  4 ( 4) 0 ( 0) 10 ( 5)
Organisations not contactable 57 (65) 45 (43) 0 ( 0) 120 (52)
Total targeted 88 (100)  105 (100) 3 (100) 196 (100)
*The web-survey method was unfortunately not set up to keep a record of refusals.
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and care (88%) and substance abuse (86%) 
organisations, and all three of the EAPs in-
dicated that their programme considered 
the role of drugs other than alcohol in HIV 
transmission and/or disease progression and/
or treatment.
Alcohol use and HIV transmission (Table 
4). Table 4 shows the frequency, amount of 
time spent per month, and modes used by 
each of the different types of organisation 
to address the links between alcohol use and 
HIV transmission, disease progression, and 
treatment among their clients. Respondents 
from all of the HIV care and treatment pro-
grammes, most (95%) of the substance abuse 
programmes, and two of the three EAPs in-
dicated that their programmes informed their 
clients about the role of alcohol use in HIV 
transmission. Table 4 shows that the HIV 
and substance abuse organisations were most 
likely to inform their clients about alcohol 
and HIV transmission via the verbal and re-
ferral routes, and least likely to do so via the 
use of written materials. Participants from 
two of the three EAPS reported using verbal 
means, one reported using written material 
and none used referrals to other organisations 
to address alcohol and HIV transmission. 
All organisations were not inclined to spend 
much time on these issues.
Alcohol use and HIV disease progression 
(Table 4). All the HIV care and treatment pro-
grammes and 93% of the substance abuse or-
ganisations reported that they informed their 
table 2: Types of HIV and Substance Abuse Programmes in the Sample
type of Service
hiV care and treatment 
Programmes (n = 25)
Substance Abuse Programmes 
(n = 56)
n (%) n (%)
Interventions in Clinical Settings 18 (72)  0 ( 0)
Interventions in Community Settings 7 (28) 31 (55)
Interventions in Rehabilitation Centres 0 ( 0) 30 (54)
Policy and Advocacy Programmes 3 (12) 17 (30)
Telephone Help-Lines 0 ( 0) 12 (21)
Screening and Brief interventions 0 ( 0) 12 (21)
Faith-Based programmes 0 ( 0)  6 (11)
Note: Percentages do not add up to 100 as some programmes could be classified as providing more than one type of service













n (%) n (%) chi-square n (--)
Alcohol Frequency Always  7 (28) 35 (63) 13.05* 1 (---)
Sometimes  8 (32) 16 (29) 2 (---)
Never 10 (40)  5 ( 9) 1 (---)
other Drugs Frequency Always  6 (24) 32 (56) 12.31* 0 (---)
Sometimes  6 (24) 15 (27) 0 (---)
Never 13 (52)  9 (16) 3 (---)
*p < .01; (---) Percentages were not calculated due to the small number of EAP respondents.
MOROJELE ET AL.
7
clients about links between alcohol use and 
HIV disease progression. Most reportedly 
addressed these links verbally, followed by 
using referrals, with a minority doing so in 
writing. The respondents from two out of the 
three EAPs reported informing their clients 
about alcohol and HIV disease progression; 
such information was given to their clients 
verbally, in writing or via referrals by two, 
one and two organisations, respectively.
Alcohol and HIV treatment (Table 4). Most 
of the respondents from the HIV programmes 
(96%), and the substance abuse organisa-
tions (93%) confirmed that they did inform 
their clients about alcohol use and its effects 
on HIV treatment. Again, most organisations 
reportedly informed their clients verbally or 
via the use of referrals, while fewer did so 
by using written materials. The participants 
from the three EAP organisations reported 
table 4: Extent to which organisations address links between alcohol use and HIV 
transmission, disease progression and HIV treatment
Area of intervention
hiV care and 
treatment 










Frequency Always 10 (40) 25 (45) 1 (---)
Sometimes 15 (60) 28 (50) 1 (---)




>10 9 (36) 18 (32) 2 (---)
1-10 15 (60) 31 (55) 0 (---)
0 1 ( 4)  7 (13) 1 (---)
Mode used to 
inform clients
Verbal 23 (92) 48 (86) 2 (---)
Written 12 (48) 11 (20) 1 (---)




Frequency Always 10 (40) 22 (39) 1 (---)
Sometimes 15 (60) 30 (54) 1 (---)




>10 8 (32) 16 (29) 2 (---)
1-10 15 (60) 32 (57) 0 (---)
0 2 ( 8) 8 (14) 1 (---)
Mode used to 
inform clients
Verbal 24 (96) 47 (84) 2 (---)
Written 11 (44) 10 (18) 1 (---)
Referral 15 (60) 23 (41) 2 (---)
Alcohol and 
hiV treatment 
Frequency Always 7 (28) 23 (41) 1 (---)
Sometimes 17 (68) 29 (52) 2 (---)




> 10 10 (40) 16 (29) 2 (---)
1-10 13 (52) 32 (57) 0 (---)
0 2 ( 8) 8 (14) 1 (---)
Mode used to 
inform clients
Verbal 22 (88) 37 (66) 3 (---)
Written 11 (44) 10 (18) 1 (---)
Referral 15 (60) 24 (43) 2 (---)
*Percentages were not calculated due to the small number of EAP respondents.
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that they did inform their clients about alco-
hol and its role in HIV treatment; three via 
the verbal route, one in writing and two by 
using referrals.
resources and information
Table 5 shows that just over two thirds of 
the respondents from both the HIV (68%) and 
substance abuse (70%) organisations reported 
having resources to address the role of alco-
hol use within the context of HIV. Based on 
counts of the responses to open-ended ques-
tions, for the HIV prevention, care and treat-
ment programmes, the most commonly re-
ported resources were pamphlets (36%) and 
counsellors (32%); while the resources that 
were most commonly available to the sub-
stance abuse programmes were counsellors 
(39%) and different medical personnel (29%). 
Other resources mentioned included videos, 
flip charts, posters, pamphlets, booklets, in-
ternet sites, rapid tests, university academics, 
medical personnel, community workers and 
volunteers. However, 24% of the respondents 
from the HIV organisations and 30% of the 
respondents from the substance abuse organi-
sations indicated that they lacked their own 
resources. Respondents from the three EAP 
organisations indicated that they did not have 
resources concerning alcohol use and HIV, but 
that they used referrals instead. Most of the 
respondents in the study indicated that they 
would be able to help their clients better if they 
had more information on alcohol use and (a) 
risky sexual behaviour; (b) immune status and 
HIV transmission; (c) immune status and HIV 
progression; and (d) coping with HIV.
general comments: findings from  
open-ended question
The final question of the survey was open-
ended and asked the participants for further 
comments. Since the comments were generally 
brief (due to the web-based and telephonic for-
mats), and the telephonic comments were not 
recorded verbatim, in this section we merely 
summarise the apparent thrust of the partici-
pants’ main comments.
One common concern that was expressed 
was of the severity of alcohol and other drug 
use problems in South Africa. Alcohol and oth-
er drug abuse in South Africa were described 
as “a pandemic”, and considered to be the 
“root cause” of many of the country’s health, 
social and economic problems. A need was ex-
pressed for more substance abuse prevention 
and treatment programmes which could be ac-
cessible to youth, as well as to people living 
with HIV and AIDS.
Concern was also expressed about the se-
verity of the HIV and AIDS epidemics and the 
public’s lack of awareness of their true impact. 
Participants felt that the government and civil 
society should exert greater effort in combat-
ing the spread of the disease (e.g. through bet-
ter prevention and confidential counselling 
services, such as via the internet) and in ad-
dressing the high mortality rate among people 
living with HIV by speeding up the roll-out of 
antiretroviral therapy services. Efficient serv-
ice delivery was reportedly hindered by budg-
etary shortages, among other factors.
Participants noted that levels of stigma 
were high and hampered treatment-seeking for 
HIV and substance abuse problems. Another 
table 5: Extent to which organisations have resources to address links between alcohol 
use and HIV transmission, disease progression and treatment
Availability of 
resources
hiV care and treatment 
Programmes (n = 25)
Substance Abuse 
Programmes (n = 56)
eAPs (n = 3)*
n (%) n (%) n (--)
Yes  17 (68) 39 (70) 0 (---)
No, but use referrals  6 (24) 17 (30) 3 (---)
No 2 ( 8)  0 ( 0) 0 (---)
*Percentages were not calculated due to the small number of EAP respondents.
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concern was that some service providers in 
substance abuse programmes were “antagonis-
tic” towards people with HIV and AIDS, and 
refrained from discussing HIV and AIDS with 
their clients unless these issues were brought 
up by clients themselves. It was also felt that 
substance abuse programmes need to give 
more prominence to the role of alcohol and 
other drug use in all aspects of HIV and AIDS.
Recognition of alcohol’s contribution to 
HIV transmission was acknowledged as im-
portant. Service providers indicated a need to 
raise awareness among young people in par-
ticular, that alcohol use rather than injection 
drug use (IDU) and needle sharing, is the pri-
mary drug of abuse that is associated with HIV 
transmission.
The participants indicated that they were 
inadequately trained to address problems of 
alcohol and its effect on HIV and AIDS and 
wanted to be able to help their clients them-
selves rather than relying on referrals. They 
also pointed to a need for more personnel in 
the clinics, to facilitate clinical service deliv-
ery on more days of the week. Furthermore, 
they identified the need for training of service 
providers, and more resources on substance 
abuse and HIV in the form of pamphlets, 
booklets, and posters in different South Afri-
can languages.
DiScuSSion
This pilot study sought to obtain a quick 
impression of the extent to which health care 
providers in HIV and substance abuse pro-
grammes as well as EAPs consider the role of 
alcohol in HIV transmission, disease progres-
sion and treatment. The findings suggest that, 
in general, health care providers in HIV care 
and treatment programmes, EAPs and sub-
stance abuse programmes are aware of and ap-
ply knowledge on the role of alcohol in HIV in 
their daily practice. This result is in line with 
the findings of Myers and Fakier (2007), who 
found that about half of the surveyed substance 
abuse services provide HIV risk reduction in-
terventions/HIV testing and counselling.
Similar types of responses emerged from the 
participants from the substance abuse and HIV 
prevention, care and treatment programmes. 
Verbal communication was most commonly 
used to inform clients about alcohol and HIV. 
This was followed by the use of referrals, fol-
lowed by the use of written materials. Howev-
er, less than one half of the health care provid-
ers from the substance abuse and HIV care and 
treatment programmes reportedly informed 
their clients about the links between alcohol 
and HIV on a routine basis
A few differences between the substance 
abuse and HIV programmes were noted. As 
expected, participants from the substance 
abuse programmes were more likely than 
those from the HIV programmes to report that 
they screened their clients for alcohol and oth-
er drug problems. However, it is advisable that 
HIV health care providers also routinely screen 
their patients for problems related to the use of 
alcohol or other drugs to enable them to iden-
tify and then appropriately advise and manage 
their clients regarding aspects of HIV disease 
that may be affected by their use of the sub-
stances. The finding that almost half of the ser-
vice providers reported never screening their 
patients for alcohol and/or other drug use is of 
concern. Only about one fifth of the substance 
abuse programmes as compared with just un-
der half of the HIV programmes had written 
materials that informed their clients about al-
cohol and its role in various aspects of HIV. 
Finally, the HIV programmes were more likely 
to use referrals (just under 2/3) than were the 
substance abuse programmes (about 2/5).
The service providers highlighted numer-
ous general concerns. For example, as found in 
previous research (Myers & Fakier, 2007), they 
considered the existing services for alcohol and 
other drug abuse problems to be inadequate. 
Similarly, participants felt that the severity of 
the HIV and AIDS epidemics were underplayed 
by society and that ART services needed to 
be scaled-up urgently. Stigma was seen to be 
prevalent with respect to HIV and AIDS and 
substance use problems and to be a deterrent 
to treatment-seeking behaviours; as it is a bar-
rier to ART adherence (Dlamini et al., 2009). 
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Indeed, some participants pointed to the reluc-
tance of some substance abuse service provid-
ers to discuss HIV and AIDS with their clients.
Participants indicated a need for more 
knowledge, specialist personnel and resourc-
es to deal with HIV and AIDS and substance 
abuse problems among clients within their or-
ganisations. The types of concerns about un-
der-resourced facilities and under-skilled staff 
that were expressed by health care workers in 
this study mirror those that have been docu-
mented elsewhere (Hall, 2004).
The study has numerous implications. 
First, it is suggested that there is a need in 
South Africa for more accessible treatment 
services for people with substance use disor-
ders in general, as well as for people living 
with HIV and AIDS in particular. Second, 
the study highlights a need for population-fo-
cused HIV awareness programmes, as well as 
community-based stigma reduction initiatives 
with accurate information about alcohol’s role 
in HIV. This is particularly important, given 
that alcohol use has been associated with HIV 
transmission (Fisher et al., 2007), the progres-
sion of HIV disease, particularly among indi-
viduals on ART (Samet et al., 2003; Miguel et 
al., 2003), and ART non-adherence (Parsons 
et al., 2005). Third, there is a need for bet-
ter integration of substance abuse and HIV 
programmes. Specifically, HIV care and treat-
ment programmes should more often screen 
their clients for alcohol and other drug-related 
problems, and substance abuse programmes 
should more actively address possible HIV 
infection among their clients. Fourth, im-
proved cross-training and support for health 
care providers are required to assist them to 
better serve and manage their clients with 
dual diagnoses. Training curricula should in-
clude more information on alcohol and HIV 
interactions and sensitise service providers to 
substance abuse and HIV and AIDS-related 
issues to reduce the stigmatisation of clients. 
This includes an increase in written resource 
material on these issues. Health care provid-
ers should also be provided with support, such 
as debriefing counselling, to reduce work-re-
lated stress and burn-out which results from 
working in challenging and under-resourced 
facilities. Finally, there is a need to support 
the further establishment and regular updating 
of comprehensive lists of HIV and substance 
abuse intervention services to guide organisa-
tions in making appropriate referrals.
Further research is required to ascertain ser-
vice providers’ understanding of how alcohol 
impacts on those at risk or already infected 
with HIV, and to obtain a clearer sense of how 
they manage these challenges. For example, 
do these programmes only provide informa-
tion or do they engage in interventions which 
facilitate behaviour change? Research is also 
needed to assess whether there is congruence 
between what health care providers report 
that they say and do, and what recipients of 
health care services report being told about 
the hazards of alcohol and other drug use on 
their behaviour and on the various aspects of 
HIV disease.
conclusion
Contrary to expectations at the outset of 
the study, many programmes in South Africa 
do consider the role of alcohol use in HIV in 
their operations, but seem to lack adequate re-
sources, information and skills to manage their 
clients effectively.
limitations
This study has a number of limitations. The 
data for the study were collected in 2005/2006 
and with the rapid changes in the state of HIV 
services in South Africa since then (Matjila, 
Hoosen, Stoltz, & Cameron, 2008), the ex-
tent to which the results would still apply at 
the time of writing (early 2009) is unclear. The 
organisations that participated in this study are 
not representative of all such programmes in 
South Africa and thus the findings may not 
be widely generalisable. The failure to access 
many of the organisations was mainly due to 
their contact details being out of date on the 
lists that were used. Although highly viable 
for certain organisations, the web-based sur-
vey method proved to not be useful for the or-
ganisations that lacked internet and electronic 
MOROJELE ET AL.
11
mail access, but telephonic interviews were 
still possible. Finally, the study was not de-
signed to ascertain the reasons underlying the 
participants’ responses although such knowl-
edge would certainly be valuable for guiding 
efforts to address many organisations’ existing 
shortcomings.
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Appendix: Brief Questionnaire Administered
Alcohol AnD hiV AuDit
Your organisation’s name:
_____________________________________________________________________________
Please answer the following questions.
1. Does your programme ever screen clients for:
Yes, always Yes, sometimes No, never Not applicable
A. Alcohol abuse and/dependence
B. Other drug use and/or dependence
2.  Does your programme inform your clients about alcohol abuse and its role in hiV transmis-
sion in the following ways?
Yes, to each 
client
Yes, to some 
clients
No Not applicable
A. Verbally (e.g. lectures, counselling)
B. In writing (e.g. pamphlets, booklets)
C. By referral
3.  Does your programme inform your clients about alcohol use and hiV disease progression 
in the following ways?
Yes, to each 
client
Yes, to some 
clients
No Not applicable
A. Verbally (e.g. lectures, counselling)
B. In writing (e.g. pamphlets, booklets)
C. By referral
4.  Does your programme inform your clients about alcohol use and hiV treatment (e.g. 
ArVs) in the following ways?
Yes, to each 
client
Yes, to some 
clients
No Not applicable
A. Verbally (e.g. lectures, counselling)
B. In writing (e.g. pamphlets, booklets)
C. By referral
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5. Would you be able to help your clients better if you had more information about:
Yes No Not applicable
A. Alcohol use and risky sexual behaviour
B. Alcohol use, immune status and HIV transmission
C. Alcohol use, immune status and HIV progression
D. Alcohol use and coping with HIV
6.  Does your programme consider the role of drugs other than alcohol in hiV transmission 
and/or disease progression and/or treatment?
Not at all A little A lot Not applicable
7. How many hours per month does your organisation consider the role of alcohol abuse in:





B. HIV disease progression
C. HIV treatment (e.g. ARVs)
8. Does your organisation have any resources that address these issues?




9. If yes, please list your organisation’s resources that are valuable in addressing these issues?
10. Do you have any further comments?
Thank you very much for your assistance.
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